Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection

Patients with end stage kidney disease receiving in-center hemodialysis (ICHD) have had high rates of SARS-CoV-2 infection. Following infection, patients receiving ICHD frequently develop circulating antibodies to SARS-CoV-2, even with asymptomatic infection. Here, we investigated the durability and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Kidney Int
Autors principals: Clarke, Candice L., Prendecki, Maria, Dhutia, Amrita, Gan, Jaslyn, Edwards, Claire, Prout, Virginia, Lightstone, Liz, Parker, Eleanor, Marchesin, Federica, Griffith, Megan, Charif, Rawya, Pickard, Graham, Cox, Alison, McClure, Myra, Tedder, Richard, Randell, Paul, Greathead, Louise, Guckian, Mary, McAdoo, Stephen P., Kelleher, Peter, Willicombe, Michelle
Format: Artigo
Idioma:Inglês
Publicat: International Society of Nephrology. Published by Elsevier Inc. 2021
Matèries:
Clinical Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7992297/
https://ncbi.nlm.nih.gov/pubmed/33774082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2021.03.009
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars